Related Experiment Videos
Characterization of sub-peak b4.2, middle molecule
Artificial Organs
|January 1, 1981
Summary
Researchers identified a specific middle molecule, b4.2, linked to uremic toxicity and polyneuropathy. This glucuronide solute, distinct from Stockholm
Area of Science:
- Nephrology
- Toxicology
- Biochemistry
Background:
- Middle molecules (MM) are implicated in uremic toxicity.
- The specific solutes responsible remain largely unidentified.
Purpose of the Study:
- To isolate and characterize middle molecules associated with uremic toxicity.
- To differentiate between MM isolated by different research groups.
Main Methods:
- Thin layer chromatography for purity assessment.
- Enzymatic and acidic hydrolysis.
- Mass spectrometry (desorption chemical ionization and electron-impact ionization).
Main Results:
- A distinct solute, b4.2, was isolated and purified.
- b4.2 was identified as a glucuronide with a molecular weight of 568 daltons (or 526 in native form).
- b4.2 is chemically different from Stockholm's peak 7c and is found in both normal urine and uremic hemofiltrate.
Conclusions:
- The isolated solute b4.2 is a potential contributor to uremic toxicity and polyneuropathy.
- b4.2 is a glucuronoconjugate of an aglycon with a molecular weight of 392 daltons (or 350 in native form).
- The characterization of b4.2 provides a new target for understanding and potentially treating uremic toxicity.